Xeris Biopharma Holdings (0A8E.L) Stock Price

$7.93 0.3%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    7

  • Fundamental

    2

  • Technical

    8

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Xeris Biopharma Holdings, AI stock picks, stock alerts and much more.

Sign up

0A8E.L AI Stock Analysis

AI stock analysis for 0A8E.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Xeris Biopharma Holdings (0A8E.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Xeris Biopharma Holdings (0A8E.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Xeris Biopharma Holdings (0A8E.L), currently trading at $7.93, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About 0A8E.L

LSE

  • Xeris Biopharma Holdings, Inc.

  • Symbol

    0A8E.L

  • Market

    LSE

  • Industry

    Biotechnology

  • Market Cap

    1.3B

Similar Stocks

0I0X.L Codexis
0I0X.L		 $2.66
0.7%
5
ONT.L Oxford Nanopore Technologies plc
ONT.L		 £195.2
2.3%
6
SAR.L Sareum Holdings
SAR.L		 £21
0.00%
5
0K1R.L Viridian Therapeutics
0K1R.L		 $18.68
0.4%
6
AVCT.L Avacta Group Plc
AVCT.L		 £52
3%
4

News

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Sees Significant Increase in Short Interest

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Sees Significant Increase in Short Interest
April 19, 2025. ETF Daily News
Vanguard Group Inc. Grows Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)

Vanguard Group Inc. Grows Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
April 15, 2025. ETF Daily News
Virtu Financial LLC Makes New $58,000 Investment in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)

Virtu Financial LLC Makes New $58,000 Investment in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
April 1, 2025. ETF Daily News
Cibc World Markets Corp Invests $44,000 in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)

Cibc World Markets Corp Invests $44,000 in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
March 29, 2025. ETF Daily News

0A8E.L Alternative Data

Web Traffic

Xeris Biopharma Holdings receives an estimated 9684 monthly visitors to xerispharma.com.

  • Web Traffic

    9684

  • Change from Previous Month

    52.2%

  • 3 Month Change

    60%

  • YoY Change

    60%

Facebook Engagement

Xeris Biopharma Holdings has engaged 0 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Job Postings

Xeris Biopharma Holdings currenly has an estimated 52 open job postings, up by 79.3% over the last month.

  • Job Postings

    52

  • Daily Change

    3.7%

  • 1 Month Change

    79.3%

  • 3 Month Change

    188.9%

  • YoY Change

    188.9%

Reddit Mentions

Xeris Biopharma Holdings has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Twitter Followers

Xeris Biopharma Holdings has 979 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.4% over the last month.

  • Twitter Followers

    979

  • Daily Change

    0%

  • 1 Month Change

    0.4%

  • 3 Month Change

    0.7%

  • YoY Change

    0.7%

Instagram Followers

Xeris Biopharma Holdings has 854 Instagram Followers on its main Instagram account, up by 2.4% over the last month.

  • Instagram Followers

    854

  • Daily Change

    0.7%

  • 1 Month Change

    2.4%

  • 3 Month Change

    4.3%

  • YoY Change

    4.3%

LinkedIn Followers

25,798 are following Xeris Biopharma Holdings on LinkedIn, up by 5.9% over the last month.

  • LinkedIn Followers

    25798

  • Daily Change

    5.9%

  • 1 Month Change

    5.9%

  • 3 Month Change

    10.7%

  • YoY Change

    10.7%

Business Outlook

According to employee reviews, the business outlook among employees at Xeris Biopharma Holdings is 63 out of 100 (bullish).

  • Business Outlook

    63

  • Change from Previous Month

    0%

  • 3 Month Change

    1.6%

  • YoY Change

    1.6%

LinkedIn Employees

According to LinkedIn, Xeris Biopharma Holdings has 415 employees, down by -1.7% over the last month.

  • LinkedIn Employees

    415

  • Daily Change

    1.7%

  • 1 Month Change

    1.7%

  • 3 Month Change

    1.2%

  • YoY Change

    1.2%

News Mentions

Xeris Biopharma Holdings was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

0A8E.L Financials

0A8E.L Key Metrics

  • Total Revenue

    $60.1M

  • Net Income

    -$5.1M

  • Earnings per Share

    -$0.0343

  • Free cash flow

    $1.8M

  • EBITDA

    $5.7M

  • EBITDA Ratio

    0.0952262

  • Total Assets

    $323.1M

0A8E.L 2-year Revenue & Income
0A8E.L 2-year Free Cash Flow

0A8E.L Technicals

0A8E.L SMA
0A8E.L RSI

FAQ

What's the current price of Xeris Biopharma Holdings (0A8E.L) Stock?
The price of an Xeris Biopharma Holdings (0A8E.L) share is $7.93.

What's the market cap of Xeris Biopharma Holdings?
The current market cap of Xeris Biopharma Holdings is 1.3B.

Should I buy or sell 0A8E.L?
Xeris Biopharma Holdings shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Xeris Biopharma Holdings is better viewed as a hold or accumulate position while waiting for further developments.

Is Xeris Biopharma Holdings a good investment?
The current analysis of Xeris Biopharma Holdings' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Xeris Biopharma Holdings' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Xeris Biopharma Holdings (0A8E.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Xeris Biopharma Holdings stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Xeris Biopharma Holdings (0A8E.L) that investors often compare it to?
Xeris Biopharma Holdings (0A8E.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Viridian Therapeutics and Avacta Group Plc.

What is the forecast for Xeris Biopharma Holdings' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Xeris Biopharma Holdings' stock price to be around $8.31 in 2026. Starting from the current price of $7.93, this represents a 4.8% change in price, indicating a neutral outlook for the stock.

How to buy Xeris Biopharma Holdings (0A8E.L) Stock?
Xeris Biopharma Holdings stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Xeris Biopharma Holdings shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.